Skip to main content
. Author manuscript; available in PMC: 2016 Jul 7.
Published in final edited form as: J Surg Oncol. 2015 Jul 7;112(1):80–85. doi: 10.1002/jso.23943

Figure 1. Median survival in all patients with pulmonary metastases from PDAC grouped by site of first metastases.

Figure 1

Among those with lung as a first and only site of metastases, median survival was 23.1 months compared to 16.5 months for those with lung first but not only metastases, 12.9 months for those with abdominal metastases before lung metastases, and 7.3 months for those with synchronous intra-abdominal and lung metastases. Using patients with lung only metastases as a reference for comparison, the hazard ratios of death are 1.5 (95% C.I. 0.94-2.45, p=0.091) for patients with lung first but not only metastases, 2.2 (95% C.I. 1.43-3.23, p<0.0001) for patients with abdominal first metastases, and 3.3 (95% C.I. 2.2-5.1, p<0.0001) for patients with synchronous abdominal and lung metastases.